Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Amortization - IntangiblesConsolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Healthequity (HQY) Tax Provisions (2016 - 2025)

Historic Tax Provisions for Healthequity (HQY) over the last 13 years, with Q4 2025 value amounting to $15.8 million.

  • Healthequity's Tax Provisions rose 297572.82% to $15.8 million in Q4 2025 from the same period last year, while for Oct 2025 it was $54.7 million, marking a year-over-year increase of 18643.13%. This contributed to the annual value of $19.3 million for FY2025, which is 1.55% up from last year.
  • Per Healthequity's latest filing, its Tax Provisions stood at $15.8 million for Q4 2025, which was up 297572.82% from $18.2 million recorded in Q3 2025.
  • In the past 5 years, Healthequity's Tax Provisions registered a high of $18.2 million during Q3 2025, and its lowest value of -$10.9 million during Q1 2022.
  • Its 5-year average for Tax Provisions is $2.4 million, with a median of $1.9 million in 2024.
  • Per our database at Business Quant, Healthequity's Tax Provisions plummeted by 168302.75% in 2021 and then skyrocketed by 297572.82% in 2025.
  • Over the past 5 years, Healthequity's Tax Provisions (Quarter) stood at -$4.1 million in 2021, then dropped by 11.06% to -$4.5 million in 2022, then skyrocketed by 241.31% to $6.4 million in 2023, then tumbled by 91.97% to $515000.0 in 2024, then skyrocketed by 2975.73% to $15.8 million in 2025.
  • Its last three reported values are $15.8 million in Q4 2025, $18.2 million for Q3 2025, and $17.0 million during Q2 2025.